Oral or injectable semaglutide: what’s the difference?

Semaglutide taken by mouth or by injection: what’s the difference?

Short answer: Semaglutide given by injection (Wegovy) results in greater weight loss on average than the tablet taken by mouth (Rybelsus), but the tablet is a fully valid alternative for those who wish to avoid injections. A doctor will decide which form is right for you.

Semaglutide is available in two forms: as a weekly injection (Wegovy) and as a daily tablet (Rybelsus). Both suppress appetite via the same mechanism, but they differ significantly in terms of how the body absorbs them, how effective they are for weight loss, and their practical pros and cons. In this blog post, you can read what semaglutide (Ozempic) is, how the two forms compare, and which choice Goodweigh will help you make.

What is the difference between oral and injectable semaglutide?

The main technical difference lies in how the medicine is absorbed by the body. Subcutaneous semaglutide has a bioavailability of around 89 per cent, which means that almost the entire dose enters the bloodstream. For the tablet, the situation is completely different: bioavailability is only 1 to 2 per cent, and in a small group of patients it is even practically zero. According to the Farmacotherapeutisch Kompas, absorption is so unpredictable that oral GLP-1 agonists are not preferred over subcutaneous formulations, particularly in patients at high cardiovascular risk.

To compensate for the low absorption, Rybelsus (oral semaglutide) contains the excipient SNAC, which facilitates absorption through the gastric mucosa. However, this only works under strict conditions: the tablet must be taken on an empty stomach with no more than 120 ml of water, and the patient must then wait at least 30 minutes before eating, drinking or taking any other medication. Such restrictions do not apply to the injection.

Rybelsus is approved for the treatment of type 2 diabetes, not primarily for weight loss. The high-dose injectable semaglutide (Wegovy 2.4 mg/week) is the only one that has official approval for obesity and overweight in adults. This distinction is also relevant to reimbursement: the indication for which you are using semaglutide determines whether reimbursement applies.

Which form is most effective for weight loss?

Injectable semaglutide results in greater weight loss on average, although the difference is smaller than one might expect. A large Phase 3 study shows that oral semaglutide 25 mg in overweight individuals led to an average weight loss of 13.6% over 68 weeks. That is an impressive result. Nevertheless, a meta-analysis of 12 randomised studies (n=6,253) shows that injectable semaglutide results in an average weight loss of 2.19 kg more than the oral form. How much weight you can lose with semaglutide also depends to a large extent on your starting weight, your lifestyle and how consistently you follow the treatment.

Below is an overview of the key differences.

Oral vs injectable semaglutide: an overview

According to current research, the injectable form is clearly preferable if maximum efficacy is the goal. Nevertheless, oral semaglutide performs significantly better than placebo and better than subcutaneous liraglutide: the PIONEER 4 study shows that oral semaglutide 14 mg led to a weight loss of 4.4 kg compared with 3.1 kg for subcutaneous liraglutide.

What are the advantages of the tablet?

The main advantage is practical: no needles, no fear of injections, no need to store pens in the fridge. For people who absolutely do not want to have injections, Rybelsus (oral semaglutide) is a serious alternative. The tablet also fits more easily into the morning routine without any medical procedures.

Furthermore, some people are already achieving very good results with the tablet. The higher doses (25 mg) that have recently been studied show that the difference compared with the injection decreases as the dose increases. For people with mild obesity or who are overweight, the tablet may be sufficient to reach their weight target.

What are the advantages of the injection?

Wegovy (high-dose semaglutide injection) provides a much more predictable effect. Its high bioavailability of ~89% means that the active dose is consistently absorbed by the body, regardless of when you eat or what other medicines you are taking. This also makes it easier for the treating doctor to optimise the dose.

Furthermore, Wegovy is the only semaglutide formulation with proven reduction in cardiovascular risks in obesity, as demonstrated in the SELECT study. Real-world research shows that treatment adherence after 18 months for injectable semaglutide is 84 per cent, compared with just 46 per cent for the oral formulation. This significant difference in treatment adherence plays an important role in the overall outcome in the long term.

A weekly injection also requires less daily discipline than a tablet, where timing and fasting are crucial to its effectiveness. Those who lower the barrier to taking the injection by linking it to a fixed day of the week usually find the practical burden to be minimal.

Are there differences in side effects between oral and injectable semaglutide?

The side effects largely overlap. Both forms cause gastrointestinal symptoms such as nausea, diarrhoea, vomiting and constipation, particularly during the titration phase. Serious but rare side effects such as acute pancreatitis and kidney failure occur with both forms. Read more about the side effects of semaglutide to get a complete picture.

However, there are two relevant differences. The tablet is more likely to cause localised gastrointestinal discomfort because the active substance is absorbed in the stomach rather than subcutaneously, and higher doses of Rybelsus are associated with more dysgeusia (taste disturbances). In some users, the injection causes a reaction at the injection site, such as redness or slight swelling. A 12-month study shows that injectable semaglutide results in greater weight loss, particularly in men, which indirectly also affects the balance between benefits and side effects at higher doses.

What does Goodweigh offer?

Goodweigh provides you with medical guidance during your treatment with semaglutide through an online consultation with one of our doctors. Based on your medical history, your preferences and your weight loss goal, the doctor will recommend the most suitable form of treatment. This ensures that a personalised assessment is always made to determine whether tablets or injections are the best choice for you.

Following the initial consultation, Goodweigh will arrange the prescriptions and the medication will be delivered discreetly to your home. Throughout the process, you’ll stay in touch with your doctor: they’ll also monitor your dosage progression and any side effects, so you’re never left on your own. A 12-month study shows that guidance and consistent treatment are crucial for ultimate weight loss, regardless of which form of semaglutide you use.

The right form of semaglutide: decide together with Goodweigh

Both oral and injectable semaglutide have been shown to be effective for weight loss. On average, the injection delivers better results and higher long-term treatment adherence. The tablet is a fully valid alternative for those who do not wish to have injections, provided that the strict dosage instructions are followed. You should decide which form is best for you in consultation with a doctor. Book an initial consultation via Goodweigh and start your treatment in a medically responsible manner.